Prescription drug · ANDA
hydrochlorothiazide NDC 60687-683
Hydrochlorothiazide 12.5 mg/1 · Capsule · Oral · American Health Packaging
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 60687-683-01 | 60687068301 | 100 BLISTER PACK in 1 CARTON (60687-683-01) / 1 CAPSULE in 1 BLISTER PACK (60687-683-11)Marketed from May 9, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- hydrochlorothiazide
- Generic name (nonproprietary)
- hydrochlorothiazide
- Active ingredients
- Hydrochlorothiazide — 12.5 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Labeler
- American Health Packaging
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 090510
- Marketing start
- Listing expires
- Other FDA classes
- Increased Diuresis (Physiologic effect)Thiazides (Chemical structure)
- Identifiers
- Product ID 60687-683_37df423d-a42d-2943-e063-6294a90aab95SPL ID 37df423d-a42d-2943-e063-6294a90aab95SPL set ID 13ed002f-c5bb-401c-891a-70b70cbd8fb6RxCUI 199903UNII 0J48LPH2TH
- Pharmacologic class
- Thiazide Diuretic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N460687068301followed by a unit qualifier and the quantityPackage 60687-0683-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Hydrochlorothiazide capsules are indicated in the management of hypertension either as the sole therapeutic agent, or in combination with other antihypertensives. Unlike potassium sparing combination diuretic products, hydrochlorothiazide capsules may be used in those patients in whom the development of hyperkalemia cannot be risked, including patients taking ACE inhibitors. Usage in Pregnancy: The routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus to unnecessary hazard. Diuretics do not prevent development of toxemia of pregnancy, and there is no satisfactory evidence that they are useful in the treatment of developed t…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 090510
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| hydrochlorothiazide | Hydrochlorothiazide 12.5 mg/1 | CapsuleOral | QPharma Inc | 42708-086 |
| hydrochlorothiazide | Hydrochlorothiazide 12.5 mg/1 | CapsuleOral | Northwind Health Company, LLC | 51655-522 |
| hydrochlorothiazide | Hydrochlorothiazide 12.5 mg/1 | CapsuleOral | Unichem Pharmaceuticals (USA), Inc. | 29300-130 |
| hydrochlorothiazide | Hydrochlorothiazide 12.5 mg/1 | CapsuleOral | A-S Medication Solutions | 50090-0724 |
| hydrochlorothiazide | Hydrochlorothiazide 12.5 mg/1 | CapsuleOral | Proficient Rx LP | 71205-161 |
| hydrochlorothiazide | Hydrochlorothiazide 12.5 mg/1 | CapsuleOral | Bryant Ranch Prepack | 71335-0067 |
| hydrochlorothiazide | Hydrochlorothiazide 12.5 mg/1 | CapsuleOral | Quality Care Products LLC | 35356-807 |